𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alvocidib potential therapy for refractory CLL

Book ID
120847959
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2007
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Current therapy for CLL
Current therapy for CLL
✍ E Montserrat πŸ“‚ Article πŸ“… 2000 πŸ› Springer 🌐 English βš– 109 KB
Preclinical assessment of curcumin as a
Preclinical assessment of curcumin as a potential therapy for B-CLL
✍ Peter C. Everett; John A. Meyers; Anthony Makkinje; Mohammed Rabbi; Adam Lerner πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 298 KB

## Abstract Curcumin, the principle component of the spice turmeric, has been used as an anti‐inflammatory medication in India and China for centuries. Recent studies, predominantly using actively dividing cell lines, have suggested that this compound could be used as a chemopreventative or therape